Trials / Unknown
UnknownNCT05259579
ARMA for Postoperative GERD After Sleeve Gastrectomy
Anti-reflux Mucosal Ablation (ARMA) for the Treatment of Postoperative Gastroesophageal Reflux After Sleeve Gastrectomy - A Pilot Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Chinese University of Hong Kong · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study is a pilot trial designed to evaluate the safety and efficacy of endoscopic anti-reflux ablation in postoperative gastroesophageal reflux after sleeve gastrectomy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Anti-reflux mucosal ablation | Mucosal ablation is planned around the cardia on the gastric side in a butterfly shape. Submucosal layer is raised by injecting saline with indigo carmine dye. Mucosal ablation is performed using the triangle-tip knife in spray coagulation mode. |
Timeline
- Start date
- 2022-02-01
- Primary completion
- 2023-01-31
- Completion
- 2023-07-31
- First posted
- 2022-02-28
- Last updated
- 2022-02-28
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT05259579. Inclusion in this directory is not an endorsement.